These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
550 related articles for article (PubMed ID: 24703097)
1. Anti-MOG antibodies in adult patients with demyelinating disorders of the central nervous system. Tanaka M; Tanaka K J Neuroimmunol; 2014 May; 270(1-2):98-9. PubMed ID: 24703097 [TBL] [Abstract][Full Text] [Related]
2. Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study. Kitley J; Waters P; Woodhall M; Leite MI; Murchison A; George J; Küker W; Chandratre S; Vincent A; Palace J JAMA Neurol; 2014 Mar; 71(3):276-83. PubMed ID: 24425068 [TBL] [Abstract][Full Text] [Related]
3. Antibodies to myelin oligodendrocyte glycoprotein in aquaporin 4 antibody seronegative longitudinally extensive transverse myelitis: Clinical and prognostic implications. Cobo-Calvo Á; Sepúlveda M; Bernard-Valnet R; Ruiz A; Brassat D; Martínez-Yélamos S; Saiz A; Marignier R Mult Scler; 2016 Mar; 22(3):312-9. PubMed ID: 26209592 [TBL] [Abstract][Full Text] [Related]
4. Neuromyelitis optica spectrum disorders: comparison of clinical and magnetic resonance imaging characteristics of AQP4-IgG versus MOG-IgG seropositive cases in the Netherlands. van Pelt ED; Wong YY; Ketelslegers IA; Hamann D; Hintzen RQ Eur J Neurol; 2016 Mar; 23(3):580-7. PubMed ID: 26593750 [TBL] [Abstract][Full Text] [Related]
5. Persisting myelin oligodendrocyte glycoprotein antibodies in aquaporin-4 antibody negative pediatric neuromyelitis optica. Rostásy K; Mader S; Hennes EM; Schanda K; Gredler V; Guenther A; Blaschek A; Korenke C; Pritsch M; Pohl D; Maier O; Kuchukhidze G; Brunner-Krainz M; Berger T; Reindl M Mult Scler; 2013 Jul; 19(8):1052-9. PubMed ID: 23257621 [TBL] [Abstract][Full Text] [Related]
6. Myelin-oligodendrocyte-glycoprotein (MOG) autoantibodies as potential markers of severe optic neuritis and subclinical retinal axonal degeneration. Havla J; Kümpfel T; Schinner R; Spadaro M; Schuh E; Meinl E; Hohlfeld R; Outteryck O J Neurol; 2017 Jan; 264(1):139-151. PubMed ID: 27844165 [TBL] [Abstract][Full Text] [Related]
8. Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype. Kitley J; Woodhall M; Waters P; Leite MI; Devenney E; Craig J; Palace J; Vincent A Neurology; 2012 Sep; 79(12):1273-7. PubMed ID: 22914827 [TBL] [Abstract][Full Text] [Related]
9. Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders. Mader S; Gredler V; Schanda K; Rostasy K; Dujmovic I; Pfaller K; Lutterotti A; Jarius S; Di Pauli F; Kuenz B; Ehling R; Hegen H; Deisenhammer F; Aboul-Enein F; Storch MK; Koson P; Drulovic J; Kristoferitsch W; Berger T; Reindl M J Neuroinflammation; 2011 Dec; 8():184. PubMed ID: 22204662 [TBL] [Abstract][Full Text] [Related]
10. Neuromyelitis optica spectrum disorders with antibodies to myelin oligodendrocyte glycoprotein or aquaporin-4: Clinical and paraclinical characteristics in Algerian patients. Bouzar M; Daoudi S; Hattab S; Bouzar AA; Deiva K; Wildemann B; Reindl M; Jarius S J Neurol Sci; 2017 Oct; 381():240-244. PubMed ID: 28991690 [TBL] [Abstract][Full Text] [Related]
11. [Anti-MOG antibody in different types of immune-mediated optic neuritis]. Kong XY; Peng JT; Liu LJ; Yan R; Zhang XJ Zhonghua Yan Ke Za Zhi; 2012 Dec; 48(12):1069-72. PubMed ID: 23336409 [TBL] [Abstract][Full Text] [Related]
12. The clinical spectrum associated with myelin oligodendrocyte glycoprotein antibodies (anti-MOG-Ab) in Thai patients. Siritho S; Sato DK; Kaneko K; Fujihara K; Prayoonwiwat N Mult Scler; 2016 Jun; 22(7):964-8. PubMed ID: 26498263 [TBL] [Abstract][Full Text] [Related]
13. Etiologies of acute demyelinating optic neuritis: an observational study of 110 patients. Deschamps R; Lecler A; Lamirel C; Aboab J; Gueguen A; Bensa C; Vignal C; Gout O Eur J Neurol; 2017 Jun; 24(6):875-879. PubMed ID: 28477397 [TBL] [Abstract][Full Text] [Related]
14. Anti-myelin oligodendrocyte glycoprotein (MOG) antibodies in a Japanese boy with recurrent optic neuritis. Tsuburaya RS; Miki N; Tanaka K; Kageyama T; Irahara K; Mukaida S; Shiraishi K; Tanaka M Brain Dev; 2015 Jan; 37(1):145-8. PubMed ID: 24582475 [TBL] [Abstract][Full Text] [Related]
15. Anti-MOG antibodies plead against MS diagnosis in an Acquired Demyelinating Syndromes cohort. Ketelslegers IA; Van Pelt DE; Bryde S; Neuteboom RF; Catsman-Berrevoets CE; Hamann D; Hintzen RQ Mult Scler; 2015 Oct; 21(12):1513-20. PubMed ID: 25662345 [TBL] [Abstract][Full Text] [Related]
16. Glycine receptor and myelin oligodendrocyte glycoprotein antibodies in Turkish patients with neuromyelitis optica. Woodhall M; Çoban A; Waters P; Ekizoğlu E; Kürtüncü M; Shugaiv E; Türkoğlu R; Akman-Demir G; Eraksoy M; Vincent A; Tüzün E J Neurol Sci; 2013 Dec; 335(1-2):221-3. PubMed ID: 24045088 [TBL] [Abstract][Full Text] [Related]
17. Clinical and MRI phenotype of children with MOG antibodies. Fernandez-Carbonell C; Vargas-Lowy D; Musallam A; Healy B; McLaughlin K; Wucherpfennig KW; Chitnis T Mult Scler; 2016 Feb; 22(2):174-84. PubMed ID: 26041801 [TBL] [Abstract][Full Text] [Related]